[Clinical effect of an equilibrating neuro and cardio sedative drug].
D000293:Adolescent; D000328:Adult; D001224:Aspartic Acid / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use*; D006980:Hyperthyroidism / Q000188:drug therapy; D008593:Menopause; D008517:Phytotherapy; D010946:Plants, Medicinal; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D011926:Rauwolfia / Q000627:therapeutic use*; D012737:Sex Factors; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014149:Tranquilizing Agents; D001224:Aspartic Acid; D006919:Hydroxyzine
Activité clinique d'une thérapeutique équilibrante neuro et cardio sédative.